Reported Adverse Events and Case Reviews Involving Ibogaine
Adverse event reporting plays a critical role in evaluating the safety of biologically active compounds, particularly when controlled clinical trials are limited. In the case of ibogaine, much of the available safety information comes from case reports, toxicology reviews, and post-event analyses rather than large-scale clinical studies. Researchers emphasize that these reports are essential for …
Reported Adverse Events and Case Reviews Involving Ibogaine Read More »